Loading...
Home 2017-04-13T01:43:52+00:00

What do we do?

Our work allows cancer drugs to be efficiently produced, and delivered to cancerous tumors in a targeted fashion that doesn’t destroy the patient’s normal healthy cells indiscriminantly. We do this by simplifying and standardizing the production of antibody drug conjugates to treat cancer, using proprietary site-selective chemistries as protein modification technologies.

Our Work

Who are we?

We are established scientists and medical professionals determined to treat people around world with superior, targeted cancer therapeutics.

Our Company

Partnership opportunities

Leverage our novel chemistries to create your superior targeted therapeutics to treat cancer.

For partners

Investment opportunities

We have two parallel development paths: platform technology with the ability to be licensed by others and our own proprietary therapeutic products to treat cancer

For investors

Latest News and Events

ADVANCED PROTEOME THERAPEUTICS CORPORATION ANNOUNCES THE APPOINTMENT OF DR. RANDAL CHASE TO ITS EXECUTIVE LEADERSHIP TEAM AND THE GRANT OF STOCK OPTIONS

Vancouver, British Columbia, February 6, 2017 – Advanced Proteome Therapeutics Corporation (“APC” or the “Company”) (TSX VENTURE: APC) (Frankfurt: 0E8) is pleased to announce the appointment of Dr. Randal Chase to its executive leadership team to help shape the Company’s future and advance its technology and business objectives in the [...]

February 6th, 2017|

We just moved into JLABS@Toronto

Advanced Proteome Therapeutics Corporation has offices in Canada at JLABS@Toronto and in Boston.

Contact Us